From a refined TME perspective, we were able to distinguish the tumor and stroma region–associated specific expression programs with the discovery of PD-L1 high expression at both the mRNA and protein levels in combinational therapy–treated CRC patients and confirmed with follow-up IHC staining. Here, CD274 is linked to neoplasm.